Ryman Healthcare Ltd ADR
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $19.4
- Today's High:
- $19.4
- Open Price:
- $19.4
- 52W Low:
- $13.03
- 52W High:
- $29.06
- Prev. Close:
- $19.4
- Volume:
- 0
Company Statistics
- Market Cap.:
- $2.67 billion
- Book Value:
- 34.035
- Revenue TTM:
- $568.84 million
- Operating Margin TTM:
- -1.94%
- Gross Profit TTM:
- $35.56 million
- Profit Margin:
- 45.33%
- Return on Assets TTM:
- -0.06%
- Return on Equity TTM:
- 6.37%
Company Profile
Ryman Healthcare Ltd ADR had its IPO on under the ticker symbol RYHTY.
The company operates in the Healthcare sector and Medical Care Facilities industry. Ryman Healthcare Ltd ADR has a staff strength of 7,200 employees.
Stock update
Shares of Ryman Healthcare Ltd ADR opened at $19.4 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $19.4 - $19.4, and closed at $19.4.
This is a 0% increase from the previous day's closing price.
A total volume of 0 shares were traded at the close of the day’s session.
In the last one week, shares of Ryman Healthcare Ltd ADR have increased by 0%.
Ryman Healthcare Ltd ADR's Key Ratios
Ryman Healthcare Ltd ADR has a market cap of $2.67 billion, indicating a price to book ratio of 0.855 and a price to sales ratio of 3.74.
In the last 12-months Ryman Healthcare Ltd ADR’s revenue was $568.84 million with a gross profit of $35.56 million and an EBITDA of $20.44 million. The EBITDA ratio measures Ryman Healthcare Ltd ADR's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Ryman Healthcare Ltd ADR’s operating margin was -1.94% while its return on assets stood at -0.06% with a return of equity of 6.37%.
In Q3, Ryman Healthcare Ltd ADR’s quarterly earnings growth was a negative -85.4% while revenue growth was a positive 13%.
Ryman Healthcare Ltd ADR’s PE and PEG Ratio
- Forward PE
- 12.9534
- Trailing PE
- 13.2877
- PEG
- 2.3606
Its diluted EPS in the last 12-months stands at $1.46 per share while it has a forward price to earnings multiple of 12.9534 and a PEG multiple of 2.3606. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Ryman Healthcare Ltd ADR’s profitability.
Ryman Healthcare Ltd ADR stock is trading at a EV to sales ratio of 7.3966 and a EV to EBITDA ratio of 5.2769. Its price to sales ratio in the trailing 12-months stood at 3.74.
Ryman Healthcare Ltd ADR stock pays annual dividends of $0.088 per share, indicating a yield of 3.65% and a payout ratio of 44.23%.
Balance sheet and cash flow metrics
- Total Assets
- $12.51 billion
- Total Liabilities
- $478.41 million
- Operating Cash Flow
- $-270271000.00
- Capital Expenditure
- $116.75 million
- Dividend Payout Ratio
- 44.23%
Ryman Healthcare Ltd ADR ended 2024 with $12.51 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $12.51 billion while shareholder equity stood at $4.66 billion.
Ryman Healthcare Ltd ADR ended 2024 with $0 in deferred long-term liabilities, $478.41 million in other current liabilities, 953239000.00 in common stock, $3.11 billion in retained earnings and $0 in goodwill. Its cash balance stood at $27.88 million and cash and short-term investments were $27.88 million. The company’s total short-term debt was $117,597,000 while long-term debt stood at $2.21 billion.
Ryman Healthcare Ltd ADR’s total current assets stands at $807.21 million while long-term investments were $9.32 billion and short-term investments were $0. Its net receivables were $733.34 million compared to accounts payable of $108.37 million and inventory worth $14.62 million.
In 2024, Ryman Healthcare Ltd ADR's operating cash flow was $-270271000.00 while its capital expenditure stood at $116.75 million.
Comparatively, Ryman Healthcare Ltd ADR paid $0.44 in dividends in 2024.
Other key metrics
- Current Trading Price
- $19.4
- 52-Week High
- $29.06
- 52-Week Low
- $13.03
- Analyst Target Price
- $
Ryman Healthcare Ltd ADR stock is currently trading at $19.4 per share. It touched a 52-week high of $29.06 and a 52-week low of $29.06. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $20.31 and 200-day moving average was $18.95 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Ryman Healthcare Ltd ADR
Similar Industry Stocks (Medical Care Facilities)
Most Active
Top Gainers
Top Losers
About
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. The company’s villages provide a range of retirement living and care options, such as independent townhouses and apartments, and serviced apartments, as well as a care center, which offers rest homes, hospitals, dementia-level care, and respite and day care services. Its villages also provide all-weather bowling green, indoor heated swimming pool and spa, gym, internal atrium, beauty and hair salons, library, dining area, bar, lounges, croquet laws, shops, and movie theatre facilities. The company owns and operates retirement village units and care units. The company was founded in 1984 and is based in Christchurch, New Zealand.